BR112023001266A2 - Medicamento para resfriado e agente antiviral - Google Patents

Medicamento para resfriado e agente antiviral

Info

Publication number
BR112023001266A2
BR112023001266A2 BR112023001266A BR112023001266A BR112023001266A2 BR 112023001266 A2 BR112023001266 A2 BR 112023001266A2 BR 112023001266 A BR112023001266 A BR 112023001266A BR 112023001266 A BR112023001266 A BR 112023001266A BR 112023001266 A2 BR112023001266 A2 BR 112023001266A2
Authority
BR
Brazil
Prior art keywords
cold
antiviral agent
drug
cold medicine
pharmaceutically acceptable
Prior art date
Application number
BR112023001266A
Other languages
English (en)
Inventor
Iwata Koushi
imai Kaoru
Original Assignee
Otsuka Pharma Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Factory Inc filed Critical Otsuka Pharma Factory Inc
Publication of BR112023001266A2 publication Critical patent/BR112023001266A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

MEDICAMENTO PARA RESFRIADO E AGENTE ANTIVIRAL. A presente invenção refere-se a um medicamento para resfriado ou agente antiviral. Um medicamento para resfriado incluindo um composto representado pela fórmula geral (1) ou um sal farmaceuticamente aceitável do mesmo.
BR112023001266A 2020-07-30 2021-06-30 Medicamento para resfriado e agente antiviral BR112023001266A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020128943 2020-07-30
PCT/JP2021/024778 WO2022024649A1 (ja) 2020-07-30 2021-06-30 感冒剤及び抗ウイルス剤

Publications (1)

Publication Number Publication Date
BR112023001266A2 true BR112023001266A2 (pt) 2023-02-14

Family

ID=80035486

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023001266A BR112023001266A2 (pt) 2020-07-30 2021-06-30 Medicamento para resfriado e agente antiviral

Country Status (11)

Country Link
US (1) US20240041854A1 (pt)
EP (1) EP4190329A4 (pt)
JP (1) JPWO2022024649A1 (pt)
KR (1) KR20230044481A (pt)
CN (1) CN116249528A (pt)
AR (1) AR123100A1 (pt)
AU (1) AU2021315149A1 (pt)
BR (1) BR112023001266A2 (pt)
CA (1) CA3190455A1 (pt)
TW (1) TW202214593A (pt)
WO (1) WO2022024649A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010026029A1 (en) * 2008-09-03 2010-03-11 Boehringer Ingelheim International Gmbh Use of quinazoline derivatives for the treatment of viral diseases
JP5540227B2 (ja) * 2009-02-04 2014-07-02 株式会社大塚製薬工場 フェニルイミダゾール化合物
KR101317318B1 (ko) * 2011-04-19 2013-10-14 원광대학교산학협력단 신종인플루엔자, 조류인플루엔자, 일반 및 독감감기, ｓａｒｓ 바이러스 억제 효능을 갖는 오배자 추출물 또는 이로부터 분리된 화합물을 유효성분으로 함유하는 약학 조성물
CN102797043B (zh) * 2011-05-23 2015-11-25 天利康（天津）科技有限公司 药物分子片段库及其构建方法
HUE058875T2 (hu) * 2015-12-25 2022-09-28 Otsuka Pharma Factory Inc Fenilimidazol vegyület

Also Published As

Publication number Publication date
EP4190329A4 (en) 2024-07-31
EP4190329A1 (en) 2023-06-07
CA3190455A1 (en) 2022-02-03
US20240041854A1 (en) 2024-02-08
TW202214593A (zh) 2022-04-16
WO2022024649A1 (ja) 2022-02-03
CN116249528A (zh) 2023-06-09
KR20230044481A (ko) 2023-04-04
JPWO2022024649A1 (pt) 2022-02-03
AR123100A1 (es) 2022-10-26
AU2021315149A1 (en) 2023-03-02

Similar Documents

Publication Publication Date Title
CL2021000382A1 (es) Compuestos novedosos de sulfonamidaurea
BR112022025037A2 (pt) Compostos antivirais para tratar infecções por coronavírus, picornavírus e norovírus
UY38425A (es) Procesos novedosos para preparar n-((1,2,3,5,6,7-hexahidro-s-indacen-4-il)carbamoil)-1- isopropil-1h-pirazol-3-sulfonamida y sales de éste
BR112019016291A2 (pt) novo composto heterocíclico, seu método de preparação e composição farmacêutica compreendendo o mesmo
CL2021001396A1 (es) Derivados de panteteína y usos de los mismos
UY38186A (es) Sal sódica de n-((1,2,3,5,6,7-hexahidro-s-indacen-4-il)carbamoil)-1-isopropil-1h-pirazol-3-sulfonamida
BR112019024831A2 (pt) composto, sal, solvato ou pró-droga, composição farmacêutica, método de tratamento ou prevenção de uma doença, método para inibir o nlrp3
BR112015029512A2 (pt) derivados de pirazolopirrolidina e seu uso no tratamento de doenças
BR112015020302A2 (pt) derivado de pirazol
BR112014025564A8 (pt) composto heterocíclico contendo nitrogênio ou sal do mesmo
UY38625A (es) Compuestos y su uso en el tratamiento del cáncer
BR112023006337A2 (pt) Produto farmacêutico, uso de um conjugado anticorpo anti-her2-fármaco ou um inibidor seletivo de parp1, e, método de tratamento do câncer
NZ600912A (en) Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection
PH12020551772A1 (en) Oxo-substituted compound
BR112021023927A2 (pt) Composto, e, composição farmacêutica
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
BR112023000770A2 (pt) Inibidor de egfr
CL2022001317A1 (es) Composición farmacéutica oral que comprende compuesto de carbamato y método de preparación para la misma.
BR112023001266A2 (pt) Medicamento para resfriado e agente antiviral
BR112022004099A2 (pt) Composto, composição farmacêutica, uso do composto, e, método para o tratamento de uma doença relacionada ao atx
BR112018003313A2 (pt) novo derivado de catecol e composição farmacêutica compreendendo o mesmo
MX2024006975A (es) Inhibidor de cdk9 y uso del mismo.
BR112023019657A2 (pt) Antagonista de abhd6
BR112022007729A2 (pt) Polipeptídeo tendo efeito mmp2-inibidor
BR112022018979A2 (pt) Medicamento para tratamento de dor